RNA Avidity Biosciences Inc Net earnings per share for the last 12 months
Changes in rolling net income per share correlate with the high-precision delivery of RNA drugs via specialized cold chains to maintain profitability. Meanwhile, the 0.00 metric indicates the status of the company, which utilizes diversified oligonucleotide transport channels to ensure testing continuity. Simultaneously, Avidity Biosciences (RNA) is implementing "green" laboratory technologies to minimize hazardous waste during biopharmaceutical synthesis.
%20Earnings%20per%20share%20for%20the%20trailing%20year&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_RNA_-_Avidity-Biosciences_-_Earnings-per-share-for-the-trailing-year "RNA - Avidity Corp Net earnings per share (EPS TTM) over the range 07/04/2022 - 11/12/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company Avidity Biosciences Inc (RNA)
- share price and expert price forecast:
- market capitalization data:
- balance sheet net asset value indicators:
- debt obligations and liquidity statistics:
Debt to Equity Avidity Biosciences|RNA - Long-Term Liabilities to Capital|Short-Term Debt to Equity Avidity|RNA - Company Total Debt Obligations|Debts to Book Capitalization Avidity Biosciences, Inc.|RNA - Company Long-Term Liabilities|Company Short-Term Debts Avidity Biosciences|Quick Ratio aviditybiosciences.com
- net income and valuation multiples indicators:
RNA - Company Net Income|Expected Profit Avidity Biosciences|RNA - Price to Earnings Multiple|Forward P/E Multiple Avidity Biosciences, Inc.|RNA - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Avidity Biosciences, Inc.|RNA - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Avidity Biosciences|RNA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months aviditybiosciences.com|RNA - Earnings per share increase in current year|Net earnings per share growth forecast for next year Avidity Biosciences
Fundamental company analysis:Avidity Biosciences (RNA)
Avidity Biosciences (RNA) delegates the synthesis of RNA drugs to external contractors, making its financial results sensitive to the operational stability of its partner network. This 12-month trend in the company's profit per share reflects the actual scalability of this model, stripping net income of the impact of share issuance to assess fundamental business efficiency and the pace of its market expansion.
Competitor analysis
TEM: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months qiagen.com|IONS (Ionis) - Net earnings per share for the last 12 months|Repligen Corp - Earnings per share for the trailing year|CRSP (CRISPR Therapeutics Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months WGS|Net earnings per share (EPS TTM) RARE|Net earnings per share for the last four quarters beamtx.com|Earnings per share for the last twelve months Sarepta SRPT|Twist Bioscience Inc (TWST) - Net earnings per one share for the last twelve months|TXG - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Intellia Corp NTLA|STOK: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months biolifesolutions.com|WVE (Wave Life Sciences Ltd.) - Net earnings per share (EPS TTM)|Maze Therapeutics, Inc. (MAZE) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) SION|PRME - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Taysha Gene Therapies TSHA|QURE: Earnings per share for the last 12 months|MeiraGTx - Net earnings per share (EPS TTM)|REGENXBIO Inc (RGNX) - Net earnings per share for the last 12 months|SLDB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocugen Pharma (OCGN)|Earnings per share for the last twelve months Pacific Biosciences|benitec.com (BNTC) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Design Therapeutics, Inc. (DSGN)|RCKT (Rocket Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months 4D Molecular Therapeutics Inc FDMT|LXEO: Earnings per share for the last 12 months|Korro Bio, Inc - Net earnings per share (EPS TTM)|EDIT - Net earnings per share (EPS TTM)|SLN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PRQR|Earnings per share for the last twelve months Codexis Inc|Earnings per share for the last 12 months SGMO (Sangamo BioSciences)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) metagenomi.co (MGX)|Net earnings per share (EPS TTM) DTIL (Precision BioSciences, Inc.)|Net earnings per share (EPS TTM) Generation Bio Co GBIO|BOLD: Net earnings per share for the last 12 months|XCUR: Earnings per share for the last twelve months|IMNN: Net earnings per share (EPS TTM)|PHIO - Net earnings per share for the last four quarters|MBIO (Mustang Bio Inc) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode)|Net earnings per share (EPS TTM) BNGO|Net earnings per share for the last four quarters Applied DNA Corp|bluebird bio, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters IPA (ImmunoPrecise Antibodies Ltd)|OMGA: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Singular Genomics Systems, Inc.|RGLS (Regulus Therapeutics Inc) - Net earnings per share for the last 12 months|Syros Pharmaceuticals, Inc - Earnings per share for the trailing year|TBIO (Telesis Bio, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months TCON|Net earnings per share (EPS TTM) UBX
